Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP631754.RATY4sBtwHZV_XjBNG3hXq3_LFe7fXu8XPPkmKAKvs_D0130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631754.RATY4sBtwHZV_XjBNG3hXq3_LFe7fXu8XPPkmKAKvs_D0130_provenance.
• NP480057.RAlom8KRSLCIvuAi-THKbq5ECESDdVJ5ijPo9Oe25cDPs130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480057.RAlom8KRSLCIvuAi-THKbq5ECESDdVJ5ijPo9Oe25cDPs130_provenance.
• NP727731.RAi3SSY9TVt3fIagHnAwAkKkpwS1SVQaLmNBIkaq3c7SQ130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727731.RAi3SSY9TVt3fIagHnAwAkKkpwS1SVQaLmNBIkaq3c7SQ130_provenance.
• NP853498.RAsQpxymyKXVtI0OJQedzM4RweKk3JxQhwxZ746nk4yRg130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853498.RAsQpxymyKXVtI0OJQedzM4RweKk3JxQhwxZ746nk4yRg130_provenance.
• NP740786.RAkF79HoRtVE4JbrY50agmUaCHTNwg3JkKdzB1NOELDMA130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740786.RAkF79HoRtVE4JbrY50agmUaCHTNwg3JkKdzB1NOELDMA130_provenance.
• NP419800.RABk5hdyxLSqoky5gPoU6ORZl6Tq5LTOhEYWx-ZFA7rdw130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419800.RABk5hdyxLSqoky5gPoU6ORZl6Tq5LTOhEYWx-ZFA7rdw130_provenance.
• NP847255.RA9Gbwt2QlFGeRlW1joZrwdIkXofbyuv11jecxMt9tMv0130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847255.RA9Gbwt2QlFGeRlW1joZrwdIkXofbyuv11jecxMt9tMv0130_provenance.
• NP419623.RA3sgXMWIBqssw2qb64JBXNzG7y2TnnFYQAz1sDX7O5k4130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419623.RA3sgXMWIBqssw2qb64JBXNzG7y2TnnFYQAz1sDX7O5k4130_provenance.
• NP419667.RA9AUWMLbvPY2oaokZSCNZWBaTZs53BYJvuvCLMGz1Q5s130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419667.RA9AUWMLbvPY2oaokZSCNZWBaTZs53BYJvuvCLMGz1Q5s130_provenance.
• NP419416.RAbHKqgrQDZRGTg-tdKlirdAb6mpXIoW7XM5ujTBk8reo130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419416.RAbHKqgrQDZRGTg-tdKlirdAb6mpXIoW7XM5ujTBk8reo130_provenance.
• NP419699.RASjeepbAeGh_YGf3B5aHM_cJwj5rj-rsZpPz3sQtvmL8130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419699.RASjeepbAeGh_YGf3B5aHM_cJwj5rj-rsZpPz3sQtvmL8130_provenance.
• NP419777.RAb7OhUN5AyQbIVeYebgrEs-FHcPmIrjthgkxeFAlmPx4130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419777.RAb7OhUN5AyQbIVeYebgrEs-FHcPmIrjthgkxeFAlmPx4130_provenance.
• assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP420152.RA9SSA-9Le-8ISTPgGy1pL-Et7QMC1-XoMhn03yhfFyKw130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420152.RA9SSA-9Le-8ISTPgGy1pL-Et7QMC1-XoMhn03yhfFyKw130_provenance.
• NP420157.RA3ZspXArHr_R9UKHUMcn2BpKQQi8GgjCuI_QCXndUEKI130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420157.RA3ZspXArHr_R9UKHUMcn2BpKQQi8GgjCuI_QCXndUEKI130_provenance.
• NP420149.RAV9wc9KloTqpUKvfwmXjFTYn0no_KWVxiY51Qut--v6k130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420149.RAV9wc9KloTqpUKvfwmXjFTYn0no_KWVxiY51Qut--v6k130_provenance.
• NP420151.RAa5LabNyJ0mkfWzKfPMvKxE4Ye2iBW8B7KetbkabBJ_E130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420151.RAa5LabNyJ0mkfWzKfPMvKxE4Ye2iBW8B7KetbkabBJ_E130_provenance.
• NP420154.RAERPOkPtZBbcu8n54Lgc07kpHZIGmvaFr6of3zizMzvU130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420154.RAERPOkPtZBbcu8n54Lgc07kpHZIGmvaFr6of3zizMzvU130_provenance.
• NP420148.RAh56NQFdact2h06a9fYLrwe_g-SzV9GW7RMAI-80K10Q130_assertion description "[We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420148.RAh56NQFdact2h06a9fYLrwe_g-SzV9GW7RMAI-80K10Q130_provenance.